Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 23.00
-0.40 (-1.71%)
Aug 3, 2026, 12:34 PM CET
EPA:BLC Cash Flow Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 60.04 | 3.12 | 2.41 | 12.75 | 14.33 | 14.35 |
Depreciation & Amortization | 59.09 | 60.64 | 55.19 | 58.76 | 59.42 | 50.8 |
Stock-Based Compensation | - | 0 | 0 | 0.85 | 0.34 | 0.38 |
Other Adjustments | 32.69 | 36.53 | 32.48 | 23.06 | 17.89 | 18.59 |
Changes in Income Taxes Payable | 1.18 | -4.55 | -9.93 | -5.23 | -6.26 | -8.53 |
Changes in Other Operating Activities | 5.63 | 5.16 | -10.06 | 14.15 | -28.86 | -1.23 |
Operating Cash Flow | 106.43 | 101.82 | 73.91 | 105.68 | 56.86 | 74.36 |
Operating Cash Flow Growth | 4.52% | 37.78% | -30.07% | 85.87% | -23.54% | 57.13% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | -49.05 | -60.08 | -49.45 | -53.63 | -53.27 | -46.51 |
Sale of Property, Plant & Equipment | -0.55 | 1.58 | 4.11 | 0.85 | 2.64 | 0.64 |
Purchases of Investments | -0.22 | -0.14 | -1.51 | -1.15 | 0 | -0.42 |
Proceeds from Sale of Investments | -1.6 | 0.27 | 0.05 | 0.15 | 0.8 | 0.09 |
Cash Acquisitions | 79.51 | 2.08 | 9.67 | -21.99 | -54.4 | -26.97 |
Other Investing Activities | -0.23 | -0.15 | -0.86 | -0.36 | -0.22 | -0.21 |
Investing Cash Flow | 27.86 | -56.44 | -37.73 | -76.25 | -104.45 | -73.38 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Long-Term Debt Issued | 1.56 | 325.56 | 56.88 | 36.97 | 256.27 | 43.03 |
Long-Term Debt Repaid | -103.45 | -329.32 | -86.39 | -29.41 | -213.84 | -30.49 |
Net Long-Term Debt Issued (Repaid) | -101.89 | -3.76 | -29.51 | 7.56 | 42.44 | 12.54 |
Issuance of Common Stock | - | 0 | 0 | 0.03 | 0.01 | 0 |
Repurchase of Common Stock | -0 | -0 | 0.02 | 0.02 | -0.24 | -0.75 |
Net Common Stock Issued (Repurchased) | -0 | -0 | 0.02 | 0.05 | -0.23 | -0.75 |
Common Dividends Paid | -0.15 | -0.57 | -1.63 | -0.61 | -2.4 | -2.14 |
Other Financing Activities | -27.62 | -29.95 | -25.1 | -13.66 | -10.38 | -8.31 |
Financing Cash Flow | -130.09 | -34.29 | -56.22 | -7.89 | 29.43 | 1.34 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Foreign Exchange Rate Adjustments | -0.39 | -0.15 | -0.01 | -0.04 | 0.09 | 0.51 |
Net Cash Flow | 3.57 | 10.95 | -20.05 | 21.51 | -18.08 | 2.83 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 57.38 | 41.74 | 24.46 | 52.05 | 3.59 | 27.85 |
Free Cash Flow Growth | 37.46% | 70.68% | -53.01% | 1351.37% | -87.12% | 269.46% |
FCF Margin | 12.05% | 8.50% | 5.30% | 10.24% | 0.77% | 6.27% |
Free Cash Flow Per Share | 7.23 | 5.26 | 3.08 | 6.56 | 0.49 | 3.79 |
Levered Free Cash Flow | -55.6 | -2.07 | -44.67 | 33.65 | 27.15 | 20.52 |
Unlevered Free Cash Flow | 87.28 | 11.54 | -10.96 | 31.14 | -14.52 | 10.9 |